News archives


OCTOBER - DECEMBER 17

JULY - SEPTEMBER 17

APRIL - JUNE 17

JANUARY - MARCH 17

OCTOBER - DECEMBER 16

JULY - SEPTEMBER 16

APRIL - JUNE 16

JANUARY - MARCH 16

OCTOBER - DECEMBER 15

JULY - SEPTEMBER 15

APRIL - JUNE 15

JANUARY - MARCH 15

OCTOBER - DECEMBER 14

JULY - SEPTEMBER 14

APRIL - JUNE 14

JANUARY - MARCH 14

OCTOBER - DECEMBER 13

JULY - SEPTEMBER 13

APRIL - JUNE 13

JANUARY - MARCH 13

OCTOBER - DECEMBER 12

JULY - SEPTEMBER 12

APRIL - JUNE 12

JANUARY - MARCH 12

OCTOBER - DECEMBER 11

JULY - SEPTEMBER 11

APRIL - JUNE 11

JANUARY - MARCH 11

OCTOBER - DECEMBER 10

JULY - SEPTEMBER 10

APRIL - JUNE 10

JANUARY - MARCH 10

OCTOBER - DECEMBER 09

JULY - SEPTEMBER 09

APRIL - JUNE 09

JANUARY - MARCH 09

OCTOBER - DECEMBER 08

JULY - SEPTEMBER 08

APRIL - JUNE 08

JANUARY - MARCH 08

OCTOBER - DECEMBER 07

JULY - SEPTEMBER 07

APRIL - JUNE 07

JANUARY - MARCH 07

 
  current news   Press   selected story    
     
  13 May 2015  
 
Hematopoiesis specific loss of Cdk2 and Cdk4 results in increased erythrocyte size and delayed platelet recovery following stress
 
 




Authors
Senthil Raja Jayapal1, Chelsia Qiuxia Wang1,2, Xavier Bisteau1, Matias J. Caldez1,3, Shuhui Lim1, Vinay Tergaonka1, Motomi Osato2, and Philipp Kaldis1,3

1  Institute of Molecular and Cell Biology, A*STAR Agency for Science, Technology and Research
2   Cancer Science Institute of Singapore, National University of Singapore
3  National University of Singapore, Department of Biochemistry, Republic of Singapore

Published in Haematologica in April 2015.

Abstract
Mouse knockouts of Cdk2 and Cdk4 are individually viable whereas the double knockouts are embryonic lethal due to heart defects, and this precludes the investigation of their overlapping roles in definitive hematopoiesis. Here we use a conditional knockout mouse model to investigate the effect of combined loss of Cdk2 and Cdk4 in hematopoietic cells. Cdk2fl/flCdk4–/–vavCre mice are viable but displayed a significant increase in erythrocyte size. Cdk2fl/flCdk4–/–vavCre mouse bone marrow exhibited reduced phosphorylation of the retinoblastoma protein and reduced expression of E2F target genes such as cyclin A2 and Cdk1. Erythroblasts lacking Cdk2 and Cdk4 displayed a lengthened G1 phase due to impaired phosphorylation of the retinoblastoma protein. Deletion of the retinoblastoma protein rescued the increased size displayed by erythrocytes lacking Cdk2 and Cdk4, indicating that the retinoblastoma/Cdk2/Cdk4 pathway regulates erythrocyte size. The recovery of platelet counts following
a 5-fluorouracil challenge was delayed in Cdk2fl/flCdk4–/–vavCre mice revealing a critical role for Cdk2 and Cdk4 in stress hematopoiesis. Our data indicate that Cdk2 and Cdk4 play important overlapping roles in homeostatic and stress hematopoiesis, which need to be considered when using broad-spectrum cyclin-dependent kinase inhibitors for cancer therapy.

Figure:

Figure Legend:Cdk2 and Cdk4 regulate erythroid cell size. (A) Two-month oldCdk2fl/flCdk4–/–vavCre (DKO) and littermate wild-type (Control) mice are shown. (B) Complete blood count data for Cdk2fl/flCdk4–/–vavCre (DKO) mice (n=6) and littermate controls (n=6, wild-type or double heterozygotes) at two months of age. Two-tailed t-test results are indicated by asterisks; *P<0.05, **P<0.01, ***P<0.001. (C) Western blot analysis of total bone marrow (BM) from 4-month old Cdk2fl/flCdk4–/–vavCre (DKO) and littermate Cdk2+/+Cdk4+/+vavCre or Cdk2+/flCdk4+/-vavCre control mice (Control) with the indicated antibodies. HSP90 and GAPDH served as loading controls.


For more information on Philipp KALDIS's laboratory, please click here.